Jazz Pharmaceuticals PLC | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
216,312.00
57,326.00
329,534.00
396,831.00
487,848.00
447,098
Depreciation, Depletion & Amortization
82,090.00
133,681.00
108,056.00
113,780.00
165,154.00
216,731
Other Funds
5,763.00
188,258.00
26,102.00
21,234.00
15,435.00
194,198
Funds from Operations
375,088.00
472,105.00
530,905.00
613,255.00
666,321.00
769,212
Changes in Working Capital
91,472.00
66,340.00
1,038.00
22,719.00
26,766.00
23,286
Net Operating Cash Flow
283,616.00
405,765.00
531,943.00
590,536.00
693,087.00
792,498
Capital Expenditures
11,276.00
36,347.00
35,958.00
181,582.00
113,950.00
Sale of Fixed Assets & Businesses
-
-
33,703.00
-
-
Purchase/Sale of Investments
-
-
-
65,275.00
155,000.00
Net Investing Cash Flow
11,276.00
1,067,649.00
2,328.00
1,749,300.00
268,950.00
Issuance/Reduction of Debt, Net
87,515.00
884,861.00
167,118.00
816,343.00
326,701.00
Net Financing Cash Flow
24,029.00
712,875.00
214,250.00
540,987.00
409,111.00
Net Change in Cash
249,308.00
47,538.00
304,743.00
622,822.00
20,072.00
Free Cash Flow
273,640.00
369,418.00
495,985.00
582,704.00
664,137.00
Deferred Taxes & Investment Tax Credit
10,097.00
43,423.00
68,358.00
41,163.00
225,591.00
88,815
Net Assets from Acquisitions
-
828,676.00
73.00
1,502,443.00
-
Change in Capital Stock
105,781.00
16,272.00
21,030.00
254,122.00
66,975.00
Exchange Rate Effect
997.00
3,453.00
10,622.00
5,045.00
5,046.00
Other Uses
-
202,626.00
-
-
-
About Jazz Pharmaceuticals
View Profile
